© Cleveland Clinic 2020
For more data like this, visit clevelandclinic.org/hvtioutcomes
HEART, VASCULAR & THORACIC
Volumes and outcomes from a sampling of centers in Cleveland Clinic’s Miller Family Heart, Vascular & Thoracic Institute
Vitals
and clevelandclinic.org/e15.
Thoracic Surgery
2,063 Number of thoracic operations in 2019, our highest annual volume to date
QUALITY
Lobectomy for Lung Cancer Composite Quality Rating
Eligible procedures
Participant score
STS mean participant score
Participant rating
500
98.9%
98.1%
(highest)
214
95.6%
90.2%
Esophagectomy Composite Quality Rating
(highest)
698
4.9%
5.5%
Combined Morbidity/Mortality for
Pulmonary Resections
Eligible procedures
Unadjusted rate
Risk-adjusted rate
Standardized incidence ratio
0.72
REDUCED INVASIVENESS
287
Number of robotically assisted thoracic surgery procedures in 2019, up 19.6% from 2018
93
Percentage of all lobectomies (N = 108) for stage I lung cancer that used video- or robot-assisted thoracoscopic surgery
3
Median length of stay (in days) following lobectomy, vs. benchmark of 4 days in STS General Thoracic Surgery Database
Lung Transplantation
123
Number of lung transplants performed in 2019 — the third-highest volume in the U.S.
98 bilateral | 25 single
313
Number of patients evaluated for lung transplantation in 2019
2,000
Cumulative lung transplants performed at Cleveland Clinic
as of July 8, 2020
75.0%
71.2%
71.4%
1/1/14-6/30/16
Observed
Expected
National
Report dates
Graft Survival | 3-year survival rates*
Patient Survival | 3-year survival rates*
76.5%
73.1%
73.3%
1/1/14-6/30/16
Observed
Expected
National
Report dates
Snapshots of Unique Populations
Hypertrophic Obstructive Cardiomyopathy (HOCM)
4,118
Number of HOCM outpatient visits in 2019, up 11% from 2018
206
Number of septal myectomies performed (isolated or in combination with other procedures) to treat HOCM in 2019, up 38% from 2018
Eligible procedures
Participant score
STS mean participant score
Participant rating
*From the most recent Scientific Registry of Transplant Recipients (SRTR) data release (1/7/20).
The following stats are from the Society of Thoracic Surgeons (STS) General Thoracic Surgery Database (3-year period ending 06/30/2019):
VOLUME
Graft Survival | 1-year survival rates*
85.9%
88.9%
88.9%
7/1/16-12/31/18
Observed
Expected
National
Report dates
Patient Survival | 1-year survival rates*
98.6%
97.5%
97.7%
7/1/16-12/31/18
Observed
Expected
National
Report dates
*From the most recent Scientific Registry of Transplant Recipients (SRTR) data release (1/7/20).
0.5%
In-hospital mortality for septal myectomies in 2019, vs. 1.8% expected mortality*
*Data from the Vizient Clinical Data Base/Resource Manager™. Used by permission of Vizient. All rights reserved.
Cardio-Oncology
1,738
Number of echoes performed for cardio-oncology patients in 2019
4%
Increase in echoes for this population over 2018
